Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Frezzetti

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Plos One|December 2, 2011
The microRNA-processing enzyme Dicer is essential for thyroid functionDaniela Frezzetti, Carla Reale, Gaetano Calì, et al.
Plos One|March 24, 2015
Selective dicer suppression in the kidney alters GSK3β/β-catenin pathways promoting a glomerulocystic diseaseAnna Iervolino, Francesco Trepiccione, Federica Petrillo, et al.
Oncotarget|May 1, 2018
RANTES and IL-6 cooperate in inducing a more aggressive phenotype in breast cancer cellsMarianna Gallo, Daniela Frezzetti, Cristin Roma, et al.
Cancers|December 22, 2020
Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and PitfallsRiziero Esposito Abate, Daniela Frezzetti, Monica Rosaria Maiello, et al.
Cells|June 25, 2026
MiR-23c Regulates the Resistance to Gefitinib in EGFR Mutant Non-Small-Cell Lung Cancer CellsBrigitta Ignoto, Ilaria Assunta Parisi, Cristin Roma, et al.
Cancers|June 23, 2019
Genomic Profiling of <i>KRAS/NRAS/BRAF/PIK3CA</i> Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR AgentsAnna Maria Rachiglio, Matilde Lambiase, Francesca Fenizia, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical DiagnosticsCristin Roma, Alessandra Sacco, Laura Forgione, et al.
International Journal of Molecular Sciences|May 11, 2024
The Impact of Inadequate Exposure to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors on the Development of Resistance in Non-Small-Cell Lung Cancer CellsDaniela Frezzetti, Vincenza Caridi, Laura Marra, et al.
Bioinformatics Advances|February 25, 2026
REDAC: RNA-seq expression data analysis chatbotGiovanni Maria De Filippis, Pranoy Sahu, Pasqualina Ambrosio, et al.
Nature Communications|March 25, 2026
First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trialAngela Damato, Riziero Esposito Abate, Simona Tessitore, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Plos One|December 2, 2011
The microRNA-processing enzyme Dicer is essential for thyroid functionDaniela Frezzetti, Carla Reale, Gaetano Calì, et al.
Plos One|March 24, 2015
Selective dicer suppression in the kidney alters GSK3β/β-catenin pathways promoting a glomerulocystic diseaseAnna Iervolino, Francesco Trepiccione, Federica Petrillo, et al.
Oncotarget|May 1, 2018
RANTES and IL-6 cooperate in inducing a more aggressive phenotype in breast cancer cellsMarianna Gallo, Daniela Frezzetti, Cristin Roma, et al.
Cancers|December 22, 2020
Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and PitfallsRiziero Esposito Abate, Daniela Frezzetti, Monica Rosaria Maiello, et al.
Cells|June 25, 2026
MiR-23c Regulates the Resistance to Gefitinib in EGFR Mutant Non-Small-Cell Lung Cancer CellsBrigitta Ignoto, Ilaria Assunta Parisi, Cristin Roma, et al.
Cancers|June 23, 2019
Genomic Profiling of <i>KRAS/NRAS/BRAF/PIK3CA</i> Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR AgentsAnna Maria Rachiglio, Matilde Lambiase, Francesca Fenizia, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical DiagnosticsCristin Roma, Alessandra Sacco, Laura Forgione, et al.
International Journal of Molecular Sciences|May 11, 2024
The Impact of Inadequate Exposure to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors on the Development of Resistance in Non-Small-Cell Lung Cancer CellsDaniela Frezzetti, Vincenza Caridi, Laura Marra, et al.
Bioinformatics Advances|February 25, 2026
REDAC: RNA-seq expression data analysis chatbotGiovanni Maria De Filippis, Pranoy Sahu, Pasqualina Ambrosio, et al.
Nature Communications|March 25, 2026
First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trialAngela Damato, Riziero Esposito Abate, Simona Tessitore, et al.
Pageof 3